Nerinetide is under clinical development by NoNO and currently in Phase III for Acute Ischemic Stroke. According to GlobalData, Phase III drugs for Acute Ischemic Stroke have a 13% phase transition ...
Acute limb ischemia occurs due to a sudden decrease in the blood flow to a limb, resulting in a potential threat to the viability of the extremity. Unfortunately, the threat is not only to the ...
The global Ischemia reperfusion injury treatment industry is expected to grow with a 6.1% CAGR during 2023 to 2033. By end use, hospitals are expected to hold 53% of the market share in 2023 for ...
Patients with diabetes or hypertension frequently present with small vessel ischemic stroke syndromes. Dubbed lacunar because of the resemblance to a small lake (lacune) deep in the brain on CT ...
Study Helps Solve Mystery Between Repeated Head Impacts in Sports and Location of Brain Degeneration in CTE Dec. 9, 2024 — A new study is helping solve the mystery as to why the brain shrinks in ...